  
- 积分
- 731
- 威望
- 731
- 包包
- 1397
|
本帖最后由 痞子的烟头 于 2010-7-24 12:47 编辑
6 @8 a1 {. a2 q S) T) p
: A: X7 S% i+ p$ b0 p1.Abstract
+ ^0 z1 V8 Z5 m. H4 d7 u6 xCarcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA) in the diagnosis of oat-cell and non-oat-cell bronchial carcinoma
/ m( ]: J, e* a- ]2 BAvailable online 6 January 2006. ( D i8 @1 g m$ K
0 Q9 w8 a" t- I
2.Formos Med Assoc. 1991 Jul;90(7):631-6.
, n+ p8 R. B& }Tissue polypeptide antigen and carcinoembryonic antigen as tumor markers in lung cancer.1 h. R3 s1 Y! a$ @8 y
Lee YC, Yang PC, Kuo SH, Luh KT.
" _7 }" V( c8 {
n+ _0 `! E4 U3。Lung Cancer. 1995 Oct;13(2):155-68.
5 a* H C8 Z4 k. vMonitoring lung cancer with tissue polypeptide antigen: an ancillary, profitable serum test to evaluate treatment response and posttreatment disease status& _% E- s* ~+ \4 O- L6 m
/ J n) R) |# E+ u3 \6 `. q
4.Immunobiology. 2004;209(7):535-44.
. q3 b- N# M, x8 O% y* ]Tumor immunotherapy with alternative reading frame peptide antigens.7 V+ M' G/ K/ O) Z
Graddis TJ, Diegel ML, McMahan CJ, Tsavler L, Laus R, Vidovic D./ ?6 j3 w1 H% f) o
' y: f- ?6 j7 S
5.Cancer Res. 1990 May 15;50(10):2997-3001.# M4 o$ j: ], O* I0 w
Polypeptide core of a human pancreatic tumor mucin antigen., K0 Q" F7 Q+ D4 R
Lan MS, Hollingsworth MA, Metzgar RS.
& s) p! _2 Z9 s% B! b. l% J( J, b7 y' t& q0 t% e8 ~
6、Ann N Y Acad Sci. 2006 Jul;1070:233-8.1 @' R: N2 R3 z& b, ?
Vasoactive intestinal peptide: the dendritic cell --> regulatory T cell axis., m$ b( L( Z7 D1 W3 O; |- k
Delgado M, Gonzalez-Rey E, Ganea D.3 X; \ V( m9 {" T% M
2 N4 D, O6 j# sDepartment of Biological Sciences, Rutgers University, Newark, NJ, USA.
: q% x5 n- s0 T0 |1 k
L. n0 F7 k0 p' N- o x; Z7.Carcinoembryonic antigen, tissue polypeptide antigen and neuron-specific enolase pleural levels used to classify small-cell and non-small-cell lung cancer patients by discriminant analysis : Paone G, De Angelis G, Greco S, Fiorucci F, Bisetti A, Amegho F. Laboratory of Clinical Pathology, S. Gallicano Institute, via S. Gallicano 25/4, 1-00153 Rome. J Cancer Res Clin Oncol 1996;122:499–503 |
|